Literature DB >> 21870994

Potential clinical insights into microRNAs and their target genes in esophageal carcinoma.

Su Q Li1, He M Wang, Xiu F Cao.   

Abstract

Esophageal carcinoma (EC) are characterized by dysregulation of microRNAs, which play an important roles as a posttranscriptional regulators in protein synthesis, and are involved in cellular processes, such as proliferation, apoptosis, and differentiation. Recently, altered miRNAs expression has been comprehensively studied in EC by high-throughput technology. Increased understanding of miRNAs target genes and their potential regulatory mechanisms have clarified the miRNAs activities and may provide exciting opportunities for cancer diagnosis and miRNA-based genetherapy. Here, we reviewed the most recently discovered miRNA target genes, with particular emphasis on the deciphering of their possible mechanisms and the potential roles in miRNAs-based tumour therapeutics.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21870994     DOI: 10.3109/1354750X.2011.608132

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  3 in total

1.  Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis.

Authors:  Hai-Wei Xie; Qing-Quan Wu; Bin Zhu; Fang-Jun Chen; Lv Ji; Su-Qing Li; Chun-Mei Wang; Yu-Suo Tong; Lei Tuo; Ming Wu; Zhi-Hua Liu; Jin Lv; Wei-Hong Shi; Xiu-Feng Cao
Journal:  Tumour Biol       Date:  2014-05-09

2.  Integrated analysis of competing endogenous RNA in esophageal carcinoma.

Authors:  Nanzheng Chen; Zhi Wang; Xiaomei Yang; Donghong Geng; Junke Fu; Yong Zhang
Journal:  J Gastrointest Oncol       Date:  2021-02

Review 3.  Association between microRNA-196a2 rs11614913, microRNA-146a rs2910164, and microRNA-423 rs6505162 polymorphisms and esophageal cancer risk: A meta-analysis.

Authors:  Hong-Hai Ji; Guang-Lei Huang; Hai-Xin Yin; Ping Xu; Si-Yang Luo; Ju-Kun Song
Journal:  Meta Gene       Date:  2015-01-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.